Ten year audit of secondary prevention in coronary bypass patients
| Autor: | Boyd J, Bloomfield P, Oram Sh, Rutledge P, Irving Rj, McRae F |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
Simvastatin Blood Pressure Audit Coronary artery bypass surgery Postoperative Complications Risk Factors Medicine Humans Letters Risk factor Coronary Artery Bypass General Environmental Science Aspirin Medical Audit business.industry Anticholesteremic Agents General Engineering General Medicine Surgery Blood pressure Cholesterol Bypass surgery Cardiothoracic surgery Emergency medicine Papers General Earth and Planetary Sciences Platelet aggregation inhibitor business Platelet Aggregation Inhibitors medicine.drug |
| Popis: | Treatment of risk factors in patients who have had coronary artery bypass surgery improves their prognosis. 1 2 A national survey performed in Britain in 1994 showed that risk factor management was suboptimal in most patients who had had bypass surgery.3 This survey was carried out before the publication of landmark trials showing the benefit of reducing cholesterol concentration. 4 5 To determine if secondary prevention has changed as the evidence has improved, we audited the management of patients who had had bypass surgery in Lothian over the past decade. We identified a random sample of 100 patients a year from 1988 to 1997 from the database of cardiothoracic surgery in our regional centre. We sent postal questionnaires to their general practitioners about current aspirin treatment, smoking status, blood pressure, and cholesterol concentration and treatment and compared responses with local audit standards. We received completed questionnaires … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|